[ad_1]
Dr Alison Cave, MHRA chief safety officer, said: “We are taking prompt action to protect patients, following detection of damage to internal components of the Emerade pens if they are dropped, which may mean they activate too early or fail to activate and deliver adrenaline.
[ad_2]
Source link
